Vyepti 100 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FA1AD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,618
Award facts
- Contract value 100% obligated
- $66,617.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $66,617.50 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of VYEPTI (eptinezumab) 100 mg/mL vials. This firm fixed-price, competitively awarded contract is scheduled for completion by January 28, 2026, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to compete successfully in open competition for federal pharmaceutical procurement. VYEPTI is a monoclonal antibody therapeutic used in migraine prevention, representing the type of specialty pharmaceutical that AmerisourceBergen regularly delivers through its federal supply chain.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. This single-award IDC serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and other critical medical commodities. AmerisourceBergen's consistent receipt of competitively awarded delivery orders demonstrates its established capability to efficiently fulfill government contracts for essential pharmaceutical requirements across military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FA1AD?
SPE2DR26FA1AD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FA1AD worth?
The government has obligated $66,618 on SPE2DR26FA1AD.
Is contract SPE2DR26FA1AD an order under another contract?
Yes. SPE2DR26FA1AD is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1AD competed?
The extent of competition for SPE2DR26FA1AD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award